Robert Porten - MedX Health President CEO, Director
| MDX Stock | CAD 0.09 0.01 10.00% |
CEO
Mr. Robert Gerhard von der Porten, MBA is Chairman of the Board of the Company. He is a wellknown and respected Senior Operating Executive, also well experienced in finance, corporate development, strategy, and implementation over a broad range of industries. since 2018.
| Tenure | 6 years |
| Professional Marks | MBA |
| Address | 1495 Bonhill Road, Mississauga, ON, Canada, L5T 1M2 |
| Phone | 905-670-4428 |
| Web | https://www.medxhealth.com |
MedX Health Management Efficiency
The company has return on total asset (ROA) of (2.7782) % which means that it has lost $2.7782 on every $100 spent on assets. This is way below average. MedX Health's management efficiency ratios could be used to measure how well MedX Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, MedX Health's Non Current Assets Total are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 199.4 K in 2024, whereas Total Assets are likely to drop slightly above 707.7 K in 2024.Similar Executives
| Found 7 records | CEO Age | ||
| Brian Chafe | Exchange Income | N/A | |
| Michael Pyle | Exchange Income | 54 | |
| Darren Francis | Exchange Income | N/A | |
| John Holliday | Rogers Sugar | N/A | |
| Scott Rook | Chemtrade Logistics Income | 57 | |
| Doron Marom | Exchange Income | N/A | |
| Michael MBA | Exchange Income | 60 | |
Management Performance
| Return On Asset | -2.78 |
MedX Health Corp Leadership Team
Elected by the shareholders, the MedX Health's board of directors comprises two types of representatives: MedX Health inside directors who are chosen from within the company, and outside directors, selected externally and held independent of MedX. The board's role is to monitor MedX Health's management team and ensure that shareholders' interests are well served. MedX Health's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, MedX Health's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jim Cooke, CFO | ||
| Gary Nest, Independent Director | ||
| David Hennigar, Independent Director | ||
| Paul Karam, Middle Europe | ||
| Stephen Lockyer, CEO Director | ||
| Michael Druhan, President Products | ||
| Robert Porten, President CEO, Director | ||
| Christopher Freeman, Corporate CFO | ||
| Naman BAMA, CEO Pres | ||
| Kenneth McKay, Independent Director | ||
| Louie Canitano, COO Products | ||
| Steven Guillen, Chairman of the Board | ||
| Daniel Kaute, Managing Europe | ||
| Scott Spearn, President CEO, Director | ||
| C Freeman, Interim Officer | ||
| Scott Naughton, Managing Operations |
MedX Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is MedX Health a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Asset | -2.78 | ||||
| Operating Margin | (7.50) % | ||||
| Current Valuation | 30.53 M | ||||
| Shares Outstanding | 261.96 M | ||||
| Shares Owned By Insiders | 6.41 % | ||||
| Shares Owned By Institutions | 0.01 % | ||||
| Number Of Shares Shorted | 47.11 K | ||||
| Price To Earning | (8.75) X | ||||
| Price To Sales | 30.43 X | ||||
| Revenue | 510.61 K |
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MedX Health Corp. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Equity Search module to search for actively traded equities including funds and ETFs from over 30 global markets.
Complementary Tools for MedX Stock analysis
When running MedX Health's price analysis, check to measure MedX Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy MedX Health is operating at the current time. Most of MedX Health's value examination focuses on studying past and present price action to predict the probability of MedX Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move MedX Health's price. Additionally, you may evaluate how the addition of MedX Health to your portfolios can decrease your overall portfolio volatility.
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Volatility Analysis Get historical volatility and risk analysis based on latest market data | |
| Price Ceiling Movement Calculate and plot Price Ceiling Movement for different equity instruments |